According to market research firm Global Industry Analyst, Diabetes is the seventh leading cause of death globally with around 387 million people affected with the disease in 2014 and expected to reach 592 million by 2035. Poor dietary habits, ageing population combined with other genetic factors expose millions of patients to possible complications that call for an effective monitoring. Hospital and governments rely on home medical systems to better control the spread of the disease and the use of Blood Glucose Monitoring (BGM) devices is getting a strong traction.
Indie Semiconductor’s ASSP (Application Specific Processors) are optimized for the needs of the application area. For example, Ernie is a microcontroller that integrates a flexible switch matrix to specifically address the glucose meter market with accuracy and flexibility.
The Switch Matrix accommodates 2 separate channels for simultaneous measurements of Glucose and Hematocrit.
Designed specifically for this market, Ernie is a full end-to-end system for Glucose metering that can replace up to 8 discrete components.
About Indie Semiconductor
Founded in 2007, Indie designs and manufactures custom, microcontroller-based chips, using ARM cores. Their design methodology enables to replace most of the contents of a printed circuit board with a single, optimal chip, reducing the product size, cost and power consumption compared with solutions based around standard, off-the-shelf components. Reliability, manufacturability and security from copying are all increased.
Headquartered in Aliso Viejo, California, Indie have design and application centers in the US, in Europe and in China, acting globally and supporting locally customers across the three continents.